GlassScriptPhysician profile
Bryan C Satterwhite
NPI 1346291325
$3,631.60
in general payments reported to CMS, 2019-2025
29 companies · $959 in 2025
The $959 reported for 2025 was more than what 85% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.22 · 2020: $179 · 2021: $578 · 2022: $197 · 2023: $464 · 2024: $1,213 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $864.91 | 2024-2025 | Krystexxa |
| Linvatec Corporation | $429.63 | 2023-2025 | Colink Vallux, Biobrace 23mm, Neospan |
| Organogenesis INC. | $411.56 | 2021-2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $304.57 | 2021-2023 | Nuzyra |
| Kerecis Limited | $275.59 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Convatec INC. | $184.72 | 2024 | |
| Stryker Corporation | $166.69 | 2020-2025 | Phalinx, Ortholoc 3di Crosscheck, Easyfuse |
| Horizon Therapeutics Plc | $135.89 | 2021-2023 | Krystexxa |
| Globus Medical, INC. | $129.80 | 2025 | Senza |
| Ossio INC | $113.88 | 2023 | |
| Nevro Corp. | $91.26 | 2022 | |
| Sanara Medtech INC. | $90.90 | 2025 | Celleraterx |
| Forma Medical | $69.76 | 2024 | Optimalakin |
| Wright Medical Technology, INC. | $54.75 | 2019-2020 | |
| Smith+Nephew, INC. | $45.45 | 2024-2025 | Grafix Pl, Stravix |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $33.84 | 2025 | |
| Cashflow Solutions, LLC | $29.53 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Heron Therapeutics, INC. | $27.19 | 2021-2022 | |
| Integra Lifesciences Corporation | $24.42 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Anika Therapeutics, INC. | $18.25 | 2021 | |
| Paragon 28, INC. | $17.65 | 2021 | |
| Abbott Laboratories | $17.44 | 2025 | Eterna |
| Orthofix Medical, INC. | $16.81 | 2020 | |
| Grt US Holding, INC. | $15.44 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.63 | 2021 | |
| Nabriva Therapeutics, Plc | $13.43 | 2021 | |
| Melinta Therapeutics, LLC | $13.31 | 2022 | |
| Bioventus LLC | $13.09 | 2024 | Exogen Ultrasound Bone Healing System |
| Biowound Solutions, INC. | $8.21 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Satterwhite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.